IRIS
EMDIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.353
EU - Europa 18.661
AS - Asia 3.006
Continente sconosciuto - Info sul continente non disponibili 150
SA - Sud America 93
AF - Africa 24
OC - Oceania 16
Totale 50.303
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.898
GB - Regno Unito 7.301
IT - Italia 2.931
UA - Ucraina 2.435
DE - Germania 1.729
DK - Danimarca 1.573
CA - Canada 1.366
CN - Cina 1.162
VN - Vietnam 1.136
SE - Svezia 808
IE - Irlanda 706
FR - Francia 360
FI - Finlandia 351
HK - Hong Kong 309
PL - Polonia 261
EU - Europa 149
SG - Singapore 115
MX - Messico 78
PK - Pakistan 58
IN - India 46
KR - Corea 43
SK - Slovacchia (Repubblica Slovacca) 42
IR - Iran 37
NL - Olanda 33
CO - Colombia 23
RU - Federazione Russa 23
RO - Romania 20
JP - Giappone 19
BD - Bangladesh 18
AT - Austria 17
CH - Svizzera 16
PE - Perù 15
BR - Brasile 14
ES - Italia 13
AM - Armenia 12
AR - Argentina 12
AU - Australia 11
EC - Ecuador 11
PT - Portogallo 11
ID - Indonesia 8
BO - Bolivia 7
SA - Arabia Saudita 7
TH - Thailandia 7
TR - Turchia 7
CZ - Repubblica Ceca 6
PH - Filippine 6
BE - Belgio 5
MG - Madagascar 5
MT - Malta 5
NZ - Nuova Zelanda 5
CI - Costa d'Avorio 4
CL - Cile 4
DO - Repubblica Dominicana 4
TW - Taiwan 4
VE - Venezuela 4
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
RS - Serbia 3
SC - Seychelles 3
TN - Tunisia 3
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
GH - Ghana 2
GR - Grecia 2
KZ - Kazakistan 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
DZ - Algeria 1
EE - Estonia 1
KG - Kirghizistan 1
MK - Macedonia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PY - Paraguay 1
ZA - Sudafrica 1
Totale 50.303
Salva come PNG Salva come JPEG
Città #
Southend 5.518
Woodbridge 2.864
Chandler 2.554
Ann Arbor 2.545
Houston 2.197
Fairfield 1.913
San Mateo 1.857
Falls Church 1.553
Dearborn 1.327
Seattle 1.190
Jacksonville 1.186
Cambridge 1.143
Wilmington 1.018
Ottawa 908
Ashburn 806
Beijing 694
Dublin 691
Stevenage 685
Portsmouth 662
Dong Ket 641
Lawrence 525
Pisa 431
Boardman 426
Montréal 406
Warsaw 254
San Diego 213
Brooklyn 197
Redwood City 160
Old Bridge 158
Rome 152
London 138
Milan 137
Central District 114
Fremont 91
Hong Kong 87
Norwalk 85
Florence 63
Washington 61
Helsinki 57
Guangzhou 51
Livorno 43
Shenzhen 43
Bratislava 42
Wayne 41
West Jordan 38
Buti 34
Seoul 31
Chiswick 30
Hounslow 29
Los Angeles 28
Frankfurt am Main 27
Kilburn 26
Nanjing 26
Genoa 25
Lucca 25
Wandsworth 25
Augusta 24
Foggia 24
Hanover 23
Bologna 22
Palermo 22
Serra 22
Simi Valley 21
Dallas 20
Kansas City 20
Toronto 20
Fuzhou 19
Padova 19
Provo 19
Islamabad 18
Kish 17
Redmond 16
Dongguan 15
Kunming 15
Nuremberg 15
Forlì 14
Hefei 14
Mexico 14
Salerno 14
Turin 14
Amsterdam 13
Chicago 13
Islington 13
Krefeld 13
Medellín 13
Medolago 13
Parma 13
Pesaro 13
Bari 12
Cascina 12
Lima 12
Perugia 12
Verona 12
Viareggio 12
Wuhan 12
Yerevan 12
Berlin 11
Jinan 11
Lahore 11
Mountain View 11
Totale 36.956
Salva come PNG Salva come JPEG
Nome #
La neuropatia diabetica 234
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 225
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 215
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 212
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 207
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 187
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 186
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 180
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 171
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 170
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 167
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 166
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 166
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 165
Nuovi strumenti di management per la gestione integrata dei percorsi assistenziali dei pazienti cronici 165
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 164
Treating chemoreflex in heart failure: modulation or demolition? 163
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 159
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 158
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 158
Development of an Electronic Medical Record for Patient Care in Cardiology 158
Medical record System for Cardiology and Cardiac Surgery 157
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure. 157
Radioimmunoassay for plasma C-type natriuretic peptide determination: a methodological evaluation 157
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 157
Building medical knowledge from real world registries: The case of heart failure 157
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 156
B-type natriuretic peptide secretion following scuba diving 155
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption 155
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 153
Attivazione adrenergica e deattivazione parasimpatica nello scompenso cardiaco. 152
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 152
Cartella clinica automatizzata per il reparto di cardiologia 151
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 151
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 151
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay of the N-terminal fragment of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. 150
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients 150
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 150
Valutazione esterna di qualità dei peptidi natriuretici BNP e NT-proBNP: risultati del programma Cardioormocheck 149
These abstracts have been selected for moderated presentations on SCREEN A. Please refer to the the PROGRAM and the infos on the screen for more details about schedule, moderators and presenters. 149
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 149
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 149
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. 148
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 148
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 148
Development of an Electronic Medical Record System for the Department of Cardiology 147
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. 147
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 147
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 147
An Open System for Managing Long Term ECG Recordings 146
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 146
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 146
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 145
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 145
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 145
Cardiac production of C-type natriuretic peptide in heart failure. 144
Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method 144
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice 143
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 143
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 143
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 143
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 143
Influence of ScaI and Natriuretic Peptide (NP) Clearance Receptor Polymorphisms of the NP System on NP Concentration in Chronic Heart Failure. 142
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I. 142
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 142
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 142
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 142
Different substrates of non-sustained ventricular tachycardia in post-infarction patients with and without left ventricular dilatation. 141
Can we measure how hot the plaque is? Not yet, but…. 141
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 141
Distribution of plasma cardiac troponin-I values in healthy subjects: pathophysiological considerations 140
ST segment/heart rate hysteresis improves the diagnostic accuracy of ECG stress test for coronary artery disease in patients with left ventricular hypertrophy 140
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 140
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 139
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 139
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 139
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism 139
Prognostic value of alveolar volume in systolic heart failure: a prospective observational study 139
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 139
Daptomycin concentrations in valve tissue and vegetation in patients with bacterial endocarditis 139
Comparison of the diagnostic accuracy of BNP and NT-proBNP in acute and chronic heart failure. Reply Letter 138
C-type natriuretic peptide and heart failure 138
Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure. 138
The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex 138
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 138
Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. 137
Update sui biomarcatori nello scompenso cardiaco. 137
New and emerging biomarkers of heart failure 136
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 136
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 136
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 135
Gamma-glutamyltransferase as a cardiovascular risk factor. 134
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. 134
Natriuretic peptide testing in primary care patients. 134
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 134
Ultrafiltration: a rational treatment for heart failure. 133
Comparison of the Diagnostic Accuracy of Brain Natriuretic Peptide (BNP) and the N-Terminal Part of the Propeptide of BNP Immunoassays in Chronic and Acute Heart Failure: A Systematic Review 133
Hyperthyroidism is associated with lengthening of ventricular repolarization. 133
When chronic heart failure intersects chronic obstructive pulmonary disease: impact on long-term prognosis 133
Reference values for urinary neutrophil gelatinase-associated lipocalin (NGAL) in pediatric age measured with a fully automated chemiluminescent platform 133
Totale 15.125
Salva come PNG Salva come JPEG
Categoria #
all - tutte 268.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 268.078
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019333 0 0 0 0 0 0 0 0 0 0 141 192
2019/20206.101 243 235 368 465 1.055 897 951 286 687 117 146 651
2020/202111.798 966 1.246 530 894 633 1.601 1.075 605 923 664 1.040 1.621
2021/20228.856 788 1.557 404 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20243.160 345 129 800 249 173 445 352 194 212 202 59 0
Totale 51.063